190 related articles for article (PubMed ID: 32532598)
21. Metallic stents in malignant biliary obstruction: prospective long-term clinical results.
Lee BH; Choe DH; Lee JH; Kim KH; Chin SY
AJR Am J Roentgenol; 1997 Mar; 168(3):741-5. PubMed ID: 9057527
[TBL] [Abstract][Full Text] [Related]
22. FOLFIRINOX goes adjuvant.
Romero D
Nat Rev Clin Oncol; 2019 Mar; 16(3):145. PubMed ID: 30659285
[No Abstract] [Full Text] [Related]
23. Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial.
Dahan L; Williet N; Le Malicot K; Phelip JM; Desrame J; Bouché O; Petorin C; Malka D; Rebischung C; Aparicio T; Lecaille C; Rinaldi Y; Turpin A; Bignon AL; Bachet JB; Seitz JF; Lepage C; François E;
J Clin Oncol; 2021 Oct; 39(29):3242-3250. PubMed ID: 34288696
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study.
Aadam AA; Evans DB; Khan A; Oh Y; Dua K
Gastrointest Endosc; 2012 Jul; 76(1):67-75. PubMed ID: 22483859
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of modified FOLFIRINOX as salvage therapy for patients with refractory advanced biliary tract cancer: a retrospective study.
Ye LF; Ren C; Bai L; Liang JY; Hu MT; Yang H; Wang ZQ; Wang FH; Xu RH; Li YH; Wang DS
Invest New Drugs; 2021 Jun; 39(3):836-845. PubMed ID: 33411209
[TBL] [Abstract][Full Text] [Related]
26. Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG).
Park HS; Kang B; Chon HJ; Im HS; Lee CK; Kim I; Kang MJ; Hwang JE; Bae WK; Cheon J; Park JO; Hong JY; Kang JH; Kim JH; Lim SH; Kim JW; Kim JW; Yoo C; Choi HJ
ESMO Open; 2021 Apr; 6(2):100049. PubMed ID: 33578192
[TBL] [Abstract][Full Text] [Related]
27. Distal malignant biliary obstruction: a prospective randomised trial comparing plastic and uncovered self-expanding metal stents in the palliation of symptomatic jaundice.
Bernon MM; Shaw J; Burmeister S; Chinnery G; Hofmeyr S; Kloppers JC; Jonas E; Krige JE
S Afr J Surg; 2018 Mar; 56(1):30-34. PubMed ID: 29638090
[TBL] [Abstract][Full Text] [Related]
28. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study.
Kullman E; Frozanpor F; Söderlund C; Linder S; Sandström P; Lindhoff-Larsson A; Toth E; Lindell G; Jonas E; Freedman J; Ljungman M; Rudberg C; Ohlin B; Zacharias R; Leijonmarck CE; Teder K; Ringman A; Persson G; Gözen M; Eriksson O
Gastrointest Endosc; 2010 Nov; 72(5):915-23. PubMed ID: 21034892
[TBL] [Abstract][Full Text] [Related]
29. Stent patency using competing risk model in unresectable pancreatic cancers inserted with biliary self-expandable metallic stent.
Eum YO; Kim YT; Lee SH; Park SW; Hwang JH; Yoon WJ; Ryu JK; Yoon YB; Han JK; Yoon CJ; Cho JH; Choi Y
Dig Endosc; 2013 Jan; 25(1):67-75. PubMed ID: 23286259
[TBL] [Abstract][Full Text] [Related]
30. New antireflux plastic stent for patients with distal malignant biliary obstruction.
Yuan XL; Wei B; Ye LS; Wu CC; Tan QH; Yao MH; Zhang YH; Zeng XH; Li Y; Zhang YY; Hu B
World J Gastroenterol; 2019 May; 25(19):2373-2382. PubMed ID: 31148908
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic bilateral stent-in-stent placement for malignant hilar obstruction using a large cell type stent.
Park JM; Lee SH; Chung KH; Jang DK; Ryu JK; Kim YT; Lee JM; Paik WH
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):633-639. PubMed ID: 27919853
[TBL] [Abstract][Full Text] [Related]
32. A Prospective Multicenter Study of a Fully Covered Metal Stent in Patients with Distal Malignant Biliary Obstruction: WATCH-2 Study.
Kogure H; Ryozawa S; Maetani I; Nakai Y; Kawakami H; Yasuda I; Mochizuki H; Iwano H; Maguchi H; Kida M; Kubota K; Mukai T; Hasebe O; Igarashi Y; Hanada K; Irisawa A; Ito K; Itoi T; Isayama H
Dig Dis Sci; 2018 Sep; 63(9):2466-2473. PubMed ID: 29218484
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of combined biliary and duodenal stenting in patients with malignant biliary and duodenal obstruction.
Kim KO; Kim TN; Lee HC
Scand J Gastroenterol; 2012 Sep; 47(8-9):962-7. PubMed ID: 22571283
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
Nakai Y; Isayama H; Kawabe T; Tsujino T; Yoshida H; Sasaki T; Tada M; Arizumi T; Yagioka H; Kogure H; Togawa O; Ito Y; Matsubara S; Hirano K; Sasahira N; Omata M
Pancreas; 2008 Nov; 37(4):405-10. PubMed ID: 18953253
[TBL] [Abstract][Full Text] [Related]
35. Polyurethane-covered metal stent for management of distal malignant biliary obstruction.
Isayama H; Komatsu Y; Tsujino T; Yoshida H; Tada M; Shiratori Y; Kawabe T; Omata M
Gastrointest Endosc; 2002 Mar; 55(3):366-70. PubMed ID: 11868010
[TBL] [Abstract][Full Text] [Related]
36. No Advantage of Expanded Polytetrafluoroethylene and Fluorinated Ethylene Propylene-Covered Stents over Uncovered Nitinol Stents for Percutaneous Palliation of Malignant Infrahilar Biliary Obstruction: Results of a Single-Center Prospective Randomized Trial.
Dhondt E; Vanlangenhove P; De Man M; Huyck L; Defreyne L
J Vasc Interv Radiol; 2020 Jan; 31(1):82-92. PubMed ID: 31627908
[TBL] [Abstract][Full Text] [Related]
37. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
Kays JK; Shahda S; Stanley M; Bell TM; O'Neill BH; Kohli MD; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):673-684. PubMed ID: 29978562
[TBL] [Abstract][Full Text] [Related]
38. Modified non-flared fully covered self-expandable metal stent versus plastic stent for preoperative biliary drainage in patients with resectable malignant biliary obstruction.
Lee HW; Moon JH; Lee YN; Chung JC; Lee TH; Choi MH; Cha SW; Cho YD; Park SH
J Gastroenterol Hepatol; 2019 Sep; 34(9):1590-1596. PubMed ID: 30618170
[TBL] [Abstract][Full Text] [Related]
39. [Cost-effectiveness trial of self-expandable metal stents and plastic biliary stents in malignant biliary obstruction].
Daróczi T; Bor R; Fábián A; Szabó E; Farkas K; Bálint A; Czakó L; Rutka M; Szűcs M; Milassin Á; Molnár T; Szepes Z
Orv Hetil; 2016 Feb; 157(7):268-74. PubMed ID: 26853728
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction.
Saleem A; Leggett CL; Murad MH; Baron TH
Gastrointest Endosc; 2011 Aug; 74(2):321-327.e1-3. PubMed ID: 21683354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
